After the genome breakthrough, biological treatments may become increasingly useful, possibly replacing drugs. The genome map also raises a host of questions about genetic engineering, including a bevy of ethical concerns. That is, no companies are publicly advertising that they will do these sorts of things nor are any yet capable. The views represented above are those of the author, and the information provided here does not constitute any tax, investment or legal advice. The historical data presented are for illustrative purposes only.
Past performance is no guarantee of future results.